IL-13 抗体
-
- 抗原 See all IL-13 (IL13) 抗体
- IL-13 (IL13) (Interleukin 13 (IL13))
-
适用
- 人
-
宿主
- 大鼠
-
克隆类型
- 单克隆
-
标记
- This IL-13 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Neutralization (Neut), Blocking Antibody (Inhibition)
- 品牌
- BD Pharmingen™
- 产品特性
-
This antibody reacts with human interleukin-13, IL-13. The immunogen used to produce the JES10-5A2 hybridoma was COS-expressed recombinant human IL-13. This is a neutralizing antibody.
BD Pharmingen™ Purified Rat Anti-Human IL-13 - Purified - Clone JES10-5A2 - Isotype Rat IgG1 - Reactivity Hu - 0.5 mg - 纯化方法
- The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
- 免疫原
- Human recombinant IL-13
- 克隆位点
- JES10
- 亚型
- IgG1
- Top Product
- Discover our top product IL13 Primary Antibody
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 浓度
- 0.5 mg/mL
- 缓冲液
- Aqueous buffered solution containing ≤0.09 % sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C
- 储存方法
- Store undiluted at 4°C.
-
-
Immunoenzymetric assay of mouse and human cytokines using NIP-labeled anti-cytokine antibodies." in: Current protocols in immunology / edited by John E. Coligan ... [et al.], Vol. Chapter 6, pp. Unit 6.20, (2008) (PubMed).
: "Concomitant in vivo production of 19 different cytokines in human tonsils." in: Immunology, Vol. 83, Issue 1, pp. 16-24, (1995) (PubMed).
: "
-
Immunoenzymetric assay of mouse and human cytokines using NIP-labeled anti-cytokine antibodies." in: Current protocols in immunology / edited by John E. Coligan ... [et al.], Vol. Chapter 6, pp. Unit 6.20, (2008) (PubMed).
-
- 抗原
- IL-13 (IL13) (Interleukin 13 (IL13))
- 别名
- IL-13 (IL13 产品)
- 别名
- IL13 antibody, IL-13 antibody, P600 antibody, Il-13 antibody, L13 antibody, interleukin 13 antibody, IL13 antibody, Il13 antibody
- 途径
- JAK/STAT Signaling, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Proton Transport
-